Portal Hypertension in Children: A Tertiary Center Experience in Turkey
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Portal hypertension (PH) and its complications have a significant impact on morbidity and mortality. This study aimed to evaluate the etiology; clinical, laboratory, and endoscopic findings; treatment approaches; long-term outcomes; and prognosis of pediatric PH. Methods: This retrospective study included 222 pediatric patients diagnosed with PH between 1998 and 2016, and data encompassing clinical, laboratory, and radiological features; treatments; and complications were analyzed. Results: The most common causes of PH were portal vein thrombosis (20.3%), progressive familial intrahepatic cholestasis (18.9%), and biliary atresia (12.2%). Among the enrolled patients, 131 (59.0%) were included in the cirrhotic group and 91 (41.0%) in the noncirrhotic group. Hepatomegaly and increased transaminase levels were more frequent in the cirrhotic group than in the non-cirrhotic group. Additionally, portal gastropathy, esophageal varices, and variceal bleeding were more frequent in the non-cirrhotic group, whereas ascites, hepatopulmonary syndrome and hepatic encephalopathy were more common in the cirrhotic group. The incidence of hepatomegaly was higher in the presinusoidal group than in the prehepatic group (p<0.001). Hyperbilirubinemia was more frequent in the prehepatic group (p=0.046). The frequency of esophageal varices was similar between the prehepatic and presinusoidal groups; however, variceal bleeding was more frequent in the prehepatic group (p=0.002). Conclusion: Extrahepatic portal vein obstruction, genetic-metabolic diseases, and biliary atresia were the most prevalent causes of PH in our country. In patients with PH, hepatomegaly, increased transaminase levels, and synthesis dysfunction were suggestive of cirrhotic PH. Notably, PH in patients without cirrhosis might be more severe than that in those with cirrhosis.
Abstract
Purpose: Portal hypertension (PH) and its complications have a significant impact on morbidity and mortality. This study aimed to evaluate the etiology; clinical, laboratory, and endoscopic findings; treatment approaches; long-term outcomes; and prognosis of pediatric PH. Methods: This retrospective study included 222 pediatric patients diagnosed with PH between 1998 and 2016, and data encompassing clinical, laboratory, and radiological features; treatments; and complications were analyzed. Results: The most common causes of PH were portal vein thrombosis (20.3%), progressive familial intrahepatic cholestasis (18.9%), and biliary atresia (12.2%). Among the enrolled patients, 131 (59.0%) were included in the cirrhotic group and 91 (41.0%) in the noncirrhotic group. Hepatomegaly and increased transaminase levels were more frequent in the cirrhotic group than in the non-cirrhotic group. Additionally, portal gastropathy, esophageal varices, and variceal bleeding were more frequent in the non-cirrhotic group, whereas ascites, hepatopulmonary syndrome and hepatic encephalopathy were more common in the cirrhotic group. The incidence of hepatomegaly was higher in the presinusoidal group than in the prehepatic group (p<0.001). Hyperbilirubinemia was more frequent in the prehepatic group (p=0.046). The frequency of esophageal varices was similar between the prehepatic and presinusoidal groups; however, variceal bleeding was more frequent in the prehepatic group (p=0.002). Conclusion: Extrahepatic portal vein obstruction, genetic-metabolic diseases, and biliary atresia were the most prevalent causes of PH in our country. In patients with PH, hepatomegaly, increased transaminase levels, and synthesis dysfunction were suggestive of cirrhotic PH. Notably, PH in patients without cirrhosis might be more severe than that in those with cirrhosis.
참고문헌 (40)
- Groszmann RJ, "Portal Hypertension Collaborative Group. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis", N Engl J Med, 353, pp.2254~2261 (2005)
- Chapin CA, "Cirrhosis and portal hypertension in the pediatric population", Clin Liver Dis, 22, pp.735~752 (2018)
- Poddar U, "Etiological spectrum of esophageal varices due to portal hypertension in Indian children : is it different from the West?", J Gastroenterol Hepatol, 23, pp.1354~1357 (2008)
- D’Amico G, "Natural history. Clinical-haemodynamic correlations. Prediction of the risk of bleeding", Baillieres Clin Gastroenterol, 11, pp.243~256 (1997)
- D’Amico G, "The treatment of portal hypertension : a meta-analytic review", Hepatology, 22, pp.332~354 (1995)
- Imanieh MH, "Etiology of portal hypertension in children : a single center’s experiences", Middle East J Dig Dis, 4, pp.206~210 (2012)
- Shashidhar H, "Propranolol in prevention of portal hypertensive hemorrhage in children : a pilot study", J Pediatr Gastroenterol Nutr, 29, pp.12~17 (1999)
- Howard ER, "Assessment of injection sclerotherapy in the management of 152 children with oesophageal varices", Br J Surg, 75, pp.404~408 (1988)
- Abd El-Hamid N, "Aetiology and management of extrahepatic portal vein obstruction in children : King’s College Hospital experience", J Pediatr Gastroenterol Nutr, 47, pp.630~634 (2008)
- Bari K, "Treatment of portal hypertension", World J Gastroenterol, 18, pp.1166~1175 (2012)
- "İstatistikler ile Aile" (2023)[URL]
- Sarı S., "Çocuklarda Karaciğer Hastalıklarının Tanı ve Tedavisi", pp.72~86 (2021), Türkiye Klinikleri
- Grimaldi C, "Portal hypertension in children", Clin Res Hepatol Gastroenterol, 36, pp.260~261 (2012)
- Peter L, "Clinical and laboratory differentiation of cirrhosis and extrahepatic portal venous obstruction in children", J Gastroenterol Hepatol, 18, pp.185~189 (2003)
- Lv Y, "Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly", Exp Biol Med(Maywood), 242, pp.744~749 (2017)
- Etzion O, "Noncirrhotic portal hypertension : An overview", Clin Liver Dis(Hoboken), 6, pp.72~74 (2015)
- Sarin SK, "Non-cirrhotic portal hypertension", Clin Liver Dis, 18, pp.451~476 (2014)
- Amarapurkar PD, "Management of coagulopathy in patients with decompensated liver cirrhosis", Int J Hepatol, 2011, pp.695470~ (2011)
- Blake JC, "Bleeding time in patients with hepatic cirrhosis", BMJ, 301, pp.12~15 (1990)
- Lisman T, "Rebalanced hemostasis in patients with liver disease : evidence and clinical consequences", Blood, 116, pp.878~885 (2010)
- Jaffe DL, "Management of portal hypertension and its complications", Med Clin North Am, 80, pp.1021~1034 (1996)
- Bozic MA, "Screening and prophylaxis for varices in children with liver disease", Curr Gastroenterol Rep, 17, pp.27~ (2015)
- Attard TM, "Mortality associated with gastrointestinal bleeding in children : A retrospective cohort study", World J Gastroenterol, 23, pp.1608~1617 (2017)
- Gugig R, "Management of portal hypertension in children", World J Gastroenterol, 18, pp.1176~1184 (2012)
- Weiss B, "Etiology and long-term outcome of extrahepatic portal vein obstruction in children", World J Gastroenterol, 16, pp.4968~4972 (2010)
- Adami MR, "Hipertensão portal em crianças : métodos não invasivos preditores de varizes esofágicas", Boletim Científico de Pediatria, 3 (2014)
- Ferri PM, "Portal vein thrombosis in children and adolescents : 20 years experience of a pediatric hepatology reference center", Arq Gastroenterol, 49, pp.69~76 (2012)
- Stewart CA, "Grading portal gastropathy : validation of a gastropathy scoring system", Am J Gastroenterol, 98, pp.1758~1765 (2003)
- Burak KW, "Portal hypertensive gastropathy and gastric antral vascular ectasia(GAVE)syndrome", Gut, 49, pp.866~872 (2001)
- Amarapurkar DN, "Stomach in portal hypertension", J Assoc Physicians India, 41, pp.638~640 (1993)
- El-Rifai N, "Gastropathy and gastritis in children with portal hypertension", J Pediatr Gastroenterol Nutr, 45, pp.137~140 (2007)
- Goel A, "Use of serum vitamin B12 level as a marker to differentiate idiopathic noncirrhotic intrahepatic portal hypertension from cryptogenic cirrhosis", Dig Dis Sci, 58, pp.179~187 (2013)
- Shneider BL, "expert panel of the Children’s Hospital of Pittsburgh of UPMC. Portal hypertension in children: expert pediatric opinion on the report of the Baveno v Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension", Pediatr Transplant, 16, pp.426~437 (2012)
- Shneider BL, "Primary prophylaxis of variceal bleeding in children and the role of MesoRex Bypass : summary of the Baveno VI pediatric satellite symposium", Hepatology, 63, pp.1368~1380 (2016)
- Cifuentes LI, "Band ligation versus sham or no intervention for primary prophylaxis of oesophageal variceal bleeding in children and adolescents with chronic liver disease or portal vein thrombosis", Cochrane Database Syst Rev, 1, pp.CD011561~ (2021)
- D’Antiga L, "Interobserver agreement on endoscopic classification of oesophageal varices in children", J Pediatr Gastroenterol Nutr, 61, pp.176~181 (2015)
- Gonçalves MEP, "Prophylactic sclerotherapy in children with esophageal varices : long-term results of a controlled prospective randomized trial", J Pediatr Surg, 35, pp.401~405 (2000)
- Ozsoylu S, "Propranolol for primary and secondary prophylaxis of variceal bleeding in children with cirrhosis", Turk J Pediatr, 42, pp.31~33 (2000)
- Turnes J, "Pharmacological reduction of portal pressure and long-term risk of first variceal bleeding in patients with cirrhosis", Am J Gastroenterol, 101, pp.506~512 (2006)
- Botha JF, "Portosystemic shunts in children : a 15-year experience", J Am Coll Surg, 199, pp.179~185 (2004)